Remdesivir and mortality reduction in COVID-19 patients: a systematized subgroup analysis of ...

Retrieved on: 2021-01-14 18:56:15

Tags for this article:

Health sciences

Health

Clinical research

Medical research

Evidence-based practices

Design of experiments

Pharmaceutical industry

COVID-19 drug development

Remdesivir

Coronavirus disease

Randomized controlled trial

Meta-analysis

Click the tags to see associated articles and topics

Remdesivir and mortality reduction in COVID-19 patients: a systematized subgroup analysis of .... View article details on HISWAI: https://www.docwirenews.com/abstracts/remdesivir-and-mortality-reduction-in-covid-19-patients-a-systematized-subgroup-analysis-of-clinical-trials/

Excerpt

Farm Hosp. 2021 Jan 13;45(1):28-31. doi: 10.7399/fh.11591. ABSTRACT. OBJECTIVE: Remdesivir has not shown survival benefit for patients with ...

Article found on: www.docwirenews.com

View Original Article